− / − MEFs
Figure S1 Confirmation of the PRMT4-deficient status of Prmt4
− / − MEFs
Lysates from Prmt4 + / + and Prmt4 − / − MEFs were immunoblotted to detect PRMT4. As expected, PRMT4 is readily detectable in Prmt4 + / + MEFs, but not in Prmt4 − / − MEFs. PABP1 is utilized as a loading control. Molecular mass in kDa is indicated.
Figure S2 Comparison of PABP1 protein stability in Prmt4
+ / + and Prmt4 − / − MEFs Protein synthesis was inhibited by the addition of 15 μg/ml cycloheximide and cell extracts were prepared either immediately (t = 0) or after the indicated times. Equal amounts of protein were immunoblotted to determine PABP1 levels and α-tubulin was utilized as a loading control. In both Prmt4 + / + and Prmt4 − / − MEFs, PABP1 is stable for at least 8 h after inhibition of its synthesis and remains weakly detectable after 24 h, indicating no significant role for PRMT4-dependent methylation in regulating PABP1 protein stability. , and PABP1 (green) intracellular distribution was visualized by confocal immunofluorescence microscopy. SG formation was marked by detection of G3BP (red) and DNA was visualized by DAPI staining (blue). This revealed that the normal nucleocytoplasmic distribution of PABP1 was unaffected by AdOX treatment, and neither were SG formation or recruitment of PABP1 to SGs. (C) Effect of AdOX treatment on PABP1 protein stability. Protein synthesis was inhibited by the addition of 15 μg/ml cycloheximide and cell extracts were prepared either immediately (t = 0) or after the indicated times. Equal amounts of protein were immunoblotted to determine PABP1 levels and α-tubulin was detected as a loading control. This showed that PABP1 was highly stable in HeLa cells and that AdOX treatment did not result in a reproducible effect on PABP1 protein stability. The structure of human PABP1 RRM4 (top right-hand panel) was modelled based on the structure of human tPABP RRM4 (PDB code 2D9P). The predicted structure of RRM4 was compared with the crystal structure of human PABP1 RRM2 (top left-hand panel) (PDB code 1CVJ) by superimposition (bottom; green, RRM2; red, RRM4). Ribbon models of the two separate RRMs are shown colour-coded for secondary structure type (cyan, β-sheet; red, α-helix; white, coil; green, turn). This shows that the predicted structure of human PABP1 RRM4 is highly similar to the solved structure of human PABP1 RRM2 and validates the use of the RRM2 structure for predicting the spatial position of modified residues in RRM4. 
